ClinicalTrialsFinder

Relapsed/Refractory Primary Central Nervous System Lymphoma Clinical Trials in Beijing, Fengtai District

1 recruitingBeijing, Fengtai District, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

Relapsed/Refractory Primary Central Nervous System LymphomaRelapsed/Refractory Central Nervous System LymphomaRelapsed/Refractory Secondary Central Nervous System Lymphoma
Beijing Boren Hospital30 enrolled1 locationNCT07555561